Webinar Date/Time: Tue, Jan 30, 2024 10:00 AM EST | 9:00 AM CT | 3:00 PM GMT | 4:00 PM CET
This webinar will delve into how organizations can foster a culture that simultaneously encourages innovative thinking and adheres to the industry's stringent risk-averse nature. The webcast will discuss whether concepts like "failing fast," typical in more flexible industries, are applicable in pharmacovigilance.
Register Free: https://www.pharmexec.com/pe/pharmacovigilance
In the ever-evolving world of pharmacovigilance, safety professionals may grapple with integrating cutting-edge innovations like artificial intelligence (AI) and machine learning (ML) into drug safety practices without compromising rigorous safety standards. This webinar will delve into how organizations can foster a culture that simultaneously encourages innovative thinking and adheres to the industry's stringent risk-averse nature. The webcast will discuss whether concepts like "failing fast," typical in more flexible industries, are applicable in pharmacovigilance. The discussion will also cover how to achieve both continuous, incremental, and transformative innovations within the strict confines of the pharmacovigilance regulatory environment.
Key Learning Objectives:
Who Should Attend:
Speakers:
Grishma Sharma
Managing Director and Global Life Sciences Safety Lead
Accenture
Grishma Sharma, Managing Director and Global Life Sciences Safety Lead at Accenture, leads the Pharmacovigilance domain book of work at Accenture across operations, advisory, and technology implementation services while driving account-level delivery and sales at key clients. Grishma has broad experience in the areas of program and project management, business process development, resource and capacity management, operations service management/performance reporting for R&D outsourcing areas, and system design across the R&D value chain.
Oleg Zvenigorodsky
Director, Medical Safety/ Innovation
Jazz Pharmaceuticals
Oleg Zvenigorodsky, PharmD, is currently Director of Medical Safety and Innovation Lead at Jazz Pharmaceuticals. With a career spanning over a decade, he has held various leadership roles at Jazz, Pinnacle 21, and Johnson & Johnson. He also has experience as a pharmacist and in academia as Assistant Professor of Pharmacy Practice. Oleg has expertise across product and project management, pharmacovigilance, software implementation, clinical operations, and strategic business planning, focused on delivering innovative solutions and driving change.
Cassie Gregson
Head of IT – Development & Late Therapeutic Areas
AstraZeneca
Robert Kelle
Senior Director Enterprise Safety and Pharmacovigilance
Oracle
Robert has over 25 years of technology leadership and consulting experience across various industries. Robert leads Oracle’s Safety customer engagement programs, including the Safety Consortium and strategic Lighthouse Customer programs. Through these programs, Oracle strives to collaborate with customers of our safety solutions (Argus Safety, Empirica, and Safety One Intake) to advance pharmacovigilance operations and improve patient safety.
Register Free: https://www.pharmexec.com/pe/pharmacovigilance
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.